tirzepatide and hot flashes came back… but you’re already on HRT?, If you’re also on a GLP-1 like Mounjaro, Zepbound or Wegovy, this might be exactly why., As you lose fat, you lose a source of estrogen — your What happens if tirzepatide gets

Early trial data from Eli Lillys published research in NEJM suggests it may produce average weight loss above 24% of body weight the highest yet seen in a pharmacologic agent for obesity

If GLP1-Ra and/or GLP1-ra/GIP dual agonists were truly showing increases in BMD then why did the seminal studies in 2021 and 2022 specifically remove the BMD data from the DEXA scans that they already tried to bury in the supplemental data (to hide the loss of LBM)

Mathews SM, Jiju V, Thomas I, Panicker JT, Kuriakose LS

Summary: There is no clinically superior day to start GLP-1 receptor agonist therapy, but beginning at a weekend or during reduced commitments allows time to monitor initial side effects